Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.

Tanaka S, Hoshino Y, Sakagami T, Fukano H, Matsui Y, Hiranuma O.

BMC Infect Dis. 2019 May 22;19(1):454. doi: 10.1186/s12879-019-4050-z.

PMID:
31117976
2.

Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases.

Yoshida C, Ichiyasu H, Ideguchi H, Hirosako S, Masunaga A, Kojima K, Saeki S, Fujii K, Sakagami T, Kohrogi H.

Respir Investig. 2019 May 13. pii: S2212-5345(18)30221-1. doi: 10.1016/j.resinv.2019.03.009. [Epub ahead of print]

PMID:
31092319
3.

Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution.

Kitamura N, Ohkouchi S, Tazawa R, Ishii H, Takada T, Sakagami T, Tanaka T, Nakata K.

ERJ Open Res. 2019 Mar 18;5(1). pii: 00190-2018. doi: 10.1183/23120541.00190-2018. eCollection 2019 Feb.

4.

The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment.

Sakata Y, Kawamura K, Ichikado K, Shingu N, Yasuda Y, Eguchi Y, Anan K, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nakano A, Sakagami T.

Lung Cancer. 2019 Apr;130:159-161. doi: 10.1016/j.lungcan.2019.02.011. Epub 2019 Feb 14.

PMID:
30885338
5.

Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.

Bamba Y, Moro H, Aoki N, Koizumi T, Ohshima Y, Watanabe S, Sakagami T, Koya T, Takada T, Kikuchi T.

BMC Infect Dis. 2019 Mar 18;19(1):263. doi: 10.1186/s12879-019-3888-4.

6.

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.

Saruwatari K, Ikeda T, Saeki S, Shingu N, Imamura K, Komatu T, Ushijima S, Maruyama H, Kashiwabara K, Tomita Y, Ichiyasu H, Fujii K, Sakagami T.

Anticancer Res. 2019 Feb;39(2):923-931. doi: 10.21873/anticanres.13195.

PMID:
30711977
7.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

8.

Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma.

Kurokawa M, Koya T, Takeuchi H, Hayashi M, Sakagami T, Ishioka K, Gon Y, Hasegawa T, Kikuchi T.

J Asthma. 2018 Nov 29:1-8. doi: 10.1080/02770903.2018.1541357. [Epub ahead of print]

PMID:
30489179
9.

Increased presepsin levels are associated with the severity of fungal bloodstream infections.

Bamba Y, Moro H, Aoki N, Koizumi T, Ohshima Y, Watanabe S, Sakagami T, Koya T, Takada T, Kikuchi T.

PLoS One. 2018 Oct 31;13(10):e0206089. doi: 10.1371/journal.pone.0206089. eCollection 2018.

10.

Influence of Adherence to Inhaled Corticosteroids and Inhaler Handling Errors on Asthma Control in a Japanese Population.

Koya T, Hasegawa T, Takasawa J, Yoshimine F, Sakagami T, Hayashi M, Suzuki E, Kikuchi T; Niigata Inhalation Treatment Study Group.

Intern Med. 2018 Dec 1;57(23):3357-3363. doi: 10.2169/internalmedicine.0986-18. Epub 2018 Aug 10.

11.

Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium.

Koizumi Y, Sakagami T, Minamiguchi H, Makino A, Aoki A, Hodohara K, Mikamo H, Andoh A, Fujiyama Y.

Med Microbiol Immunol. 2019 Feb;208(1):33-37. doi: 10.1007/s00430-018-0555-0. Epub 2018 Aug 6.

PMID:
30083859
12.

Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody.

Takada T, Ohashi K, Hayashi M, Asakawa K, Sakagami T, Kikuchi T, Sato S.

Respir Med. 2018 Aug;141:7-13. doi: 10.1016/j.rmed.2018.06.012. Epub 2018 Jun 15.

PMID:
30053975
13.

Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies.

Miyashita K, Matsuura S, Tajima K, Tajima S, Aoki A, Sakagami T, Koshimizu N, Toyoshima M, Suda T.

Intern Med. 2018 Oct 15;57(20):3041-3045. doi: 10.2169/internalmedicine.0965-18. Epub 2018 May 18.

14.

A Cluster Analysis of Bronchial Asthma Patients with Depressive Symptoms.

Seino Y, Hasegawa T, Koya T, Sakagami T, Mashima I, Shimizu N, Muramatsu Y, Muramatsu K, Suzuki E, Kikuchi T; Niigata Respiratory Disease Study Group.

Intern Med. 2018 Jul 15;57(14):1967-1975. doi: 10.2169/internalmedicine.9073-17. Epub 2018 Mar 9.

15.

Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis.

Ueda T, Sakagami T, Kikuchi T, Takada T.

Respir Investig. 2018 Jan;56(1):14-20. doi: 10.1016/j.resinv.2017.11.004. Epub 2017 Dec 6. Review.

PMID:
29325675
16.

Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.

Aoki A, Sakagami T, Yoshizawa K, Shima K, Toyama M, Tanabe Y, Moro H, Aoki N, Watanabe S, Koya T, Hasegawa T, Morimoto K, Kurashima A, Hoshino Y, Trapnell BC, Kikuchi T.

Clin Infect Dis. 2018 Apr 3;66(8):1239-1245. doi: 10.1093/cid/cix996.

PMID:
29126235
17.

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.

Tanaka T, Watanabe S, Takahashi M, Sato K, Saida Y, Baba J, Arita M, Sato M, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Aoki N, Ohshima Y, Sakagami T, Abe T, Moro H, Koya T, Tanaka J, Kagamu H, Yoshizawa H, Kikuchi T.

PLoS One. 2017 Aug 30;12(8):e0183976. doi: 10.1371/journal.pone.0183976. eCollection 2017.

18.

Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.

Koizumi Y, Sakagami T, Nishiyama N, Hirai J, Hayashi Y, Asai N, Yamagishi Y, Kato H, Hagihara M, Sakanashi D, Suematsu H, Ogawa K, Mikamo H.

J Clin Immunol. 2017 Oct;37(7):644-649. doi: 10.1007/s10875-017-0425-3. Epub 2017 Aug 5.

PMID:
28779413
19.

Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.

Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J.

Diagn Microbiol Infect Dis. 2017 Aug;88(4):308-315. doi: 10.1016/j.diagmicrobio.2017.05.011. Epub 2017 May 18. Review.

PMID:
28633901
20.

Disseminated Mycobacterium genavense Infection in Patient with Adult-Onset Immunodeficiency.

Asakura T, Namkoong H, Sakagami T, Hasegawa N, Ohkusu K, Nakamura A.

Emerg Infect Dis. 2017 Jul;23(7):1208-1210. doi: 10.3201/eid2307.161677.

Supplemental Content

Loading ...
Support Center